BDBM790994 US20260034252, Compound RTX-1356R

SMILES CC(C)Cc1ccc(CCCC(=O)NCCCCC(NC(=O)C(CCCCNC(=O)CN2CCN(CC(=O)O)CCN(CC(=O)O)CCN(C(=O)O)CC2)NC(=O)CCOCCOCCOCCNC(=O)COc2ccc3c(C(=O)NCC(=O)N4CCCC4B(O)O)ccnc3c2)C(=O)O)cc1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 790994   

TargetProlyl endopeptidase FAP(Human)
Ratio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 790994BDBM790994(US20260034252, Compound RTX-1356R)
Affinity DataIC50: 0.300nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent